ELISA analyzers market was valued at USD 608.0 million in 2025 and is estimated at USD 622.0 million in 2026. The 24LifeSciences market report projects the market to reach USD 746.0 million by 2034, representing a 2.3% CAGR during 2026-2034. Demand remains linked to clinical diagnostics, immunoassay workflows and laboratory research requiring consistent microplate-based analysis.
Access the complete report: https://www.24lifesciences.com/elisa-analyzers-market-7610
Download segment insights: https://www.24lifesciences.com/download-sample/7610/elisa-analyzers-market
Emerging Trends Shaping Market Evolution
Laboratories are increasingly using automated and integrated microplate platforms to improve throughput, reproducibility and workflow efficiency. Modern absorbance readers support common 96- and 384-well formats and wavelengths used in ELISA workflows. Integration of automation, software and data handling is becoming increasingly important as laboratories manage higher test volumes and stronger quality requirements.
Key Market Drivers Supporting Growth
- Growth of immunoassay-based clinical diagnostics
- Expansion of pharmaceutical and biotechnology research
- Laboratory automation and higher-throughput testing requirements
- Need for reproducible optical measurement and workflow standardization
- Increasing adoption of integrated and multimode microplate readers
Access the complete report: https://www.24lifesciences.com/elisa-analyzers-market-7610
Download segment insights: https://www.24lifesciences.com/download-sample/7610/elisa-analyzers-market
Segment Insights & Regional Overview
The report segments the market by analyzer architecture into dedicated absorbance ELISA readers, multimode/integrated microplate readers and automated ELISA workstations. Applications include clinical diagnostics, pharmaceutical and biotechnology research, academic and life-science research, and other laboratory applications. End users include hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, academic and research institutes, and public-health laboratories. North America is the largest region in 2025.
Competitive Landscape: Key Companies
Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Tecan Group Ltd.; Revvity, Inc.; Molecular Devices, LLC; DiaSorin S.p.A.; Abbott Laboratories.
Access the complete report: https://www.24lifesciences.com/elisa-analyzers-market-7610
Download segment insights: https://www.24lifesciences.com/download-sample/7610/elisa-analyzers-market
Strategic Outlook
The market is expected to develop steadily as laboratories balance automation investment with established ELISA workflows. Competitive differentiation is likely to center on optical performance, throughput, software integration, service and compatibility with diverse assay formats.
Key Benefits of the 24LifeSciences Report
- Detailed market segmentation and application-level analysis
- Regional market assessment and forecast outlook
- Competitive landscape and company profiling
- Identification of growth drivers, trends and market opportunities
- Strategic insights for manufacturers, investors and healthcare decision-makers
About 24LifeSciences
24LifeSciences provides market intelligence and strategic research covering pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services and related life-science industries. Its research reports are designed to provide market sizing, forecasts, segmentation, regional analysis and competitive insights for business and strategic planning.
Website: https://www.24lifesciences.com
